🧠 Neuralink Expands: Canada Approves Brain Chip Trials

Neuralink, Elon Musk’s brain interface company, has received approval from Canada’s Ministry of Health to begin clinical trials outside the U.S. The first procedures will take place at Toronto Western Hospital, which will serve as the exclusive surgical center.

Key facts:
Trials target individuals with quadriplegia or ALS. Participant recruitment is now open.
A coin-sized implant will be inserted into the brain using the R1 surgical robot.
The focus: evaluate safety, surgical precision, and initial brain-computer interface functionality.

What this means: Canada’s approval isn’t just about expansion; it’s a step toward global acceptance of a technology that could transform lives for people with disabilities.
However, concerns about safety and ethics remain. While it’s a promising future, some still question if humanity is ready for AI-integrated brains.

Would you trust your brain to AI? 🤔